Breaking News Instant updates and real-time market news.

WLTW

Willis Towers Watson

$195.59

0.4 (0.20%)

07:04
07/11/19
07/11
07:04
07/11/19
07:04

Willis Towers Watson price target raised to $225 from $210 at SunTrust

SunTrust analyst Mark Hughes raised his price target on Willis Towers Watson to $225 and kept his Buy rating, saying the company's fundamentals improved during Q2 in at least two of its segments - Investment, Risk & Reinsurance and Corporate Risk & Broking. The analyst adds that the relative valuation discount on the stock should "narrow over time" as the management pursues its growth strategy, while the company also benefits from the closing of the "high-growth" Tranzact acquisition.

  • 20

    Aug

  • 21

    Aug

  • 22

    Aug

WLTW Willis Towers Watson
$195.59

0.4 (0.20%)

04/08/19
MKMP
04/08/19
NO CHANGE
Target $210
MKMP
Buy
Willis Towers Watson price target raised to $210 from $190 at MKM Partners
MKM Partners analyst Harry Fong raised his price target on Willis Towers Watson to $210and kept his Buy rating after its latest TRANZACT acquisition, saying the deal positions the company for two new Health Reimbursement Arrangements to be launched in the next two years. The analyst notes that TRANZACT will "enhance Willis's capabilities in the direct-to-consumer channel with Medicare and other products", complementing the company's Liazon and Extend Health units facilitating transition from group health plan due to retirement into a Medicare plan. Fong also states that while Medicare business grows at a low single-digit rate, the potential growth rate for the individual HRA business could be "significantly higher."
04/08/19
RBCM
04/08/19
NO CHANGE
RBCM
Outperform
eHealth guidance still 'looks conservative', says RBC Capital
RBC Capital analyst Frank Morgan kept his Outperform rating on eHealth (EHTH), stating that its valuation is supported by the $1.4B deal by WillisTowers Watson (WLTW) to acquire Tranzact which is also validating his bullish MA thesis. The analyst also notes that the stock has performed well in an otherwise "difficult healthcare tape", in part because of its "strong growth prospects in a niche not perceived as a problem with the healthcare system."
04/17/19
RHCO
04/17/19
NO CHANGE
RHCO
Buy
eHealth pullback presents 'very attractive' entry point, says SunTrust
SunTrust analyst Tobey Sommer said he views the mid-teen percentage decline in eHealth (EHTH) shares amid worries about Medicare for all proposals as presenting a "very attractive" entry point, noting that applying the same multiple paid by Willis Towers Watson (WLTW) for Tranzact implies a $62 share price for eHealth. While eHealth has a lower EBITDA margin, its revenue is growing faster and it has exposure in the individual and small business markets as well as the main Medicare business. The analyst, who believes eHealth's multi-year top-line growth outlook is substantially superior to consensus forecasts, driven by superior Medicare growth, keeps a Buy rating on the shares.
07/11/19
WELS
07/11/19
UPGRADE
Target $220
WELS
Outperform
Willis Towers Watson upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo Securities analyst Elyse Greenspan upgraded Willis Towers Watson to Outperform from Market Perform and raised her price target for the shares to $220 from $175. The analyst sees a "strong set-up" into the company's Q2 results.

TODAY'S FREE FLY STORIES

VISL

Vislink

$1.01

-0.165 (-14.10%)

07:50
07/23/19
07/23
07:50
07/23/19
07:50
Hot Stocks
Vislink receives orders valued at $1.6M for satellite communications equipment »

Vislink Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$52.87

0.62 (1.19%)

07:49
07/23/19
07/23
07:49
07/23/19
07:49
Recommendations
Six Flags analyst commentary  »

Six Flags attendance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HAL

Halliburton

$23.76

2.02 (9.29%)

07:49
07/23/19
07/23
07:49
07/23/19
07:49
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 13

    Nov

TIGR

UP Fintech

$4.29

-0.38 (-8.14%)

07:49
07/23/19
07/23
07:49
07/23/19
07:49
Hot Stocks
UP Fintech reports approval for capital markets license in Singapore »

UP Fintech Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$23.76

2.02 (9.29%)

07:48
07/23/19
07/23
07:48
07/23/19
07:48
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 13

    Nov

MARA

Marathon Patent Group

$2.13

-0.08 (-3.62%)

07:48
07/23/19
07/23
07:48
07/23/19
07:48
Hot Stocks
Marathon Patent Group receives Nasdaq acceptance of plan to regain compliance »

Marathon Patent Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$144.97

-0.28 (-0.19%)

, BBBY

Bed Bath & Beyond

$9.35

-0.56 (-5.65%)

07:46
07/23/19
07/23
07:46
07/23/19
07:46
Recommendations
Wayfair, Bed Bath & Beyond, Macy's analyst commentary  »

Wayfair well positioned…

W

Wayfair

$144.97

-0.28 (-0.19%)

BBBY

Bed Bath & Beyond

$9.35

-0.56 (-5.65%)

M

Macy's

$22.10

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 05

    Aug

IDRA

Idera Pharmaceuticals

$2.54

0.02 (0.79%)

07:46
07/23/19
07/23
07:46
07/23/19
07:46
Hot Stocks
Idera Pharmaceuticals appoints Elizabeth Tarka as CMO, John Kirby as CFO »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$225.97

1.455 (0.65%)

07:46
07/23/19
07/23
07:46
07/23/19
07:46
Recommendations
Air Products analyst commentary  »

Air Products price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

  • 22

    Aug

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:45
07/23/19
07/23
07:45
07/23/19
07:45
Hot Stocks
Marinus Pharmaceuticals announces data from Phase 2 Amaryllis study »

The Amaryllis Study…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:44
07/23/19
07/23
07:44
07/23/19
07:44
Hot Stocks
Marinus Pharmaceuticals announces data from Phase 2 Magnolia clinical trial »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

07:43
07/23/19
07/23
07:43
07/23/19
07:43
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$60.62

0.77 (1.29%)

07:43
07/23/19
07/23
07:43
07/23/19
07:43
Recommendations
Itron analyst commentary  »

Canaccord sees several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:41
07/23/19
07/23
07:41
07/23/19
07:41
Hot Stocks
RedHill Biopharma continues to enroll patients in Phase 2a study of YELIVA »

The ongoing Phase 2a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FBP

First BanCorp

$10.74

-0.25 (-2.27%)

07:40
07/23/19
07/23
07:40
07/23/19
07:40
Earnings
First BanCorp reports Q2 EPS 19c, consensus 19c »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:40
07/23/19
07/23
07:40
07/23/19
07:40
Hot Stocks
RedHill Biopharma 'working toward' confirmatory Phase 3 study for BEKINDA »

RedHill is currently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

07:40
07/23/19
07/23
07:40
07/23/19
07:40
General news
Treasury Market Outlook: Treasury yields are modestly cheaper »

Treasury Market Outlook:…

ATI

Allegheny Technologies

$25.11

-0.175 (-0.69%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Earnings
Allegheny Technologies reports Q2 ex-items EPS 40c, consensus 34c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Hot Stocks
RedHill Biopharma to initiate Phase 3 study activities with RHB-204 in Q4 »

RedHill plans to initiate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

NOW

ServiceNow

$293.30

3.48 (1.20%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Recommendations
ServiceNow analyst commentary at Needham »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Hot Stocks
RedHill Biopharma says FDA meetings for RHB-104 to take place in 2H198 »

FDA meetings are planned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:38
07/23/19
07/23
07:38
07/23/19
07:38
Hot Stocks
RedHill Biopharma plans U.S. launch of Talicia in 4Q19 »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CR

Crane

$86.50

0.99 (1.16%)

, CIR

Circor

$39.83

1.17 (3.03%)

07:37
07/23/19
07/23
07:37
07/23/19
07:37
Recommendations
Crane, Circor analyst commentary  »

Crane Q2 highlighted by…

CR

Crane

$86.50

0.99 (1.16%)

CIR

Circor

$39.83

1.17 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 09

    Sep

  • 09

    Sep

RLGY

Realogy

$5.17

-0.08 (-1.52%)

, AMZN

Amazon.com

$1,985.93

21.15 (1.08%)

07:37
07/23/19
07/23
07:37
07/23/19
07:37
Hot Stocks
Realogy launches TurnKey in collaboration with Amazon »

Realogy (RLGY) announced…

RLGY

Realogy

$5.17

-0.08 (-1.52%)

AMZN

Amazon.com

$1,985.93

21.15 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 08

    Aug

AN

AutoNation

$42.01

-0.045 (-0.11%)

07:36
07/23/19
07/23
07:36
07/23/19
07:36
Recommendations
AutoNation analyst commentary  »

Stephens 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.